Literature DB >> 19224161

Induction of apoptosis of human colon cancer cells by siRNA recombinant expression vector targeting survivin gene.

Ming Cai1, Guobin Wang, Kaixiong Tao, Changxue Cai.   

Abstract

This study constructed siRNA recombinant expression vector targeting survivin gene and observe the apoptosis induction effect of it in human colon cancer cells. siRNA recombinant expression vector targeting survivin gene was constructed and transfected into human colon cancer cells. The effect of siRNA recombinant expression vector was detected by RT-PCR, Western blot, MTT reduction assay and flow cytometry. It was confirmed by restriction endonuclease and sequence analysis that siRNA recombinant expression vector targeting survivin gene was constructed successfully. Inhibition rate of survivin siRNA at mRNA and protein levels was 36.33% and 44.65% respectively. Growth of cancer cells was inhibited and the apoptosis rate was (17.24+/-2.13)%. The siRNA recombinant expression vector targeting survivin gene has been constructed successfully. It not only can inhibit the expression of survivin gene, but also can induce apoptosis in human colon cancer cells remarkably.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224161     DOI: 10.1007/s11596-009-0109-1

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  43 in total

1.  Survivin modulates microtubule dynamics and nucleation throughout the cell cycle.

Authors:  Jack Rosa; Pedro Canovas; Ashraful Islam; Dario C Altieri; Stephen J Doxsey
Journal:  Mol Biol Cell       Date:  2006-01-11       Impact factor: 4.138

Review 2.  The case for survivin as a regulator of microtubule dynamics and cell-death decisions.

Authors:  Dario C Altieri
Journal:  Curr Opin Cell Biol       Date:  2006-08-24       Impact factor: 8.382

Review 3.  Strategies for silencing human disease using RNA interference.

Authors:  Daniel H Kim; John J Rossi
Journal:  Nat Rev Genet       Date:  2007-03       Impact factor: 53.242

Review 4.  Survivin as a target for new anticancer interventions.

Authors:  Nadia Zaffaroni; Marzia Pennati; Maria Grazia Daidone
Journal:  J Cell Mol Med       Date:  2005 Apr-Jun       Impact factor: 5.310

Review 5.  Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.

Authors:  Casey W Wright; Colin S Duckett
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

6.  A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy.

Authors:  R A Olie; A P Simões-Wüst; B Baumann; S H Leech; D Fabbro; R A Stahel; U Zangemeister-Wittke
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

7.  Expression of survivin protein in human colorectal carcinogenesis.

Authors:  Lian-Jie Lin; Chang-Qing Zheng; Yu Jin; Ying Ma; Wei-Guo Jiang; Tie Ma
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

8.  Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

Authors:  Jae Yeon Chun; Yan Hu; Elaine Pinder; Jianguo Wu; Fengzhi Li; Allen C Gao
Journal:  Mol Cancer Ther       Date:  2007-09       Impact factor: 6.261

9.  Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.

Authors:  Csaba Mahotka; Thomas Krieg; Andreas Krieg; Michael Wenzel; Christoph V Suschek; Manfred Heydthausen; Helmut E Gabbert; Claus D Gerharz
Journal:  Int J Cancer       Date:  2002-07-01       Impact factor: 7.396

10.  Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo.

Authors:  Sally P Wheatley; Alexander J Henzing; Helen Dodson; Walid Khaled; William C Earnshaw
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

View more
  2 in total

1.  The N-methyl-d-aspartate receptor in heart development: a gene knockdown model using siRNA.

Authors:  Octavian V Lie; Gregory D Bennett; Thomas H Rosenquist
Journal:  Reprod Toxicol       Date:  2009-09-06       Impact factor: 3.143

2.  Evaluation of antitumor activity of survivin short interfering RNA delivered by lipid nanoparticles in colon cancer in vitro and in vivo.

Authors:  Tianyou Wang; Ziqin Liu; Zhaoxia Zhang; Suoqin Tang; Mei Yue; Shunqiao Feng; Mengze Hu; Litian Xuan; Yanfei Chen
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.